Harleen Kaur, Assistant Professor, Department of Climate Change and Agricultural Meteorology, PAU, won the “Best Oral ...

KalVista Pharmaceuticals, Inc. today announced that six abstracts have been accepted for presentation at the American Academy of Allergy, Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug ...

A Cleveland County judge ruled the petition aiming to send the entertainment district project containing OU's new arena to a public vote was invalid.

The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, ...

MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal ...

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

Consumer Analyst Group of New York Conference (CAGNY) 2025 February 21, 2025 8:00 AM ETCompany ParticipantsNoel ...

And welcome to the Fourth Quarter 2024 Hawaiian Electric Industries, Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET. The ...